| Sign In to gain access to subscriptions and/or personal tools. |
Efficacy of Adcon-T/N After Primary Flexor Tendon Repair in Zone II: A Controlled Clinical TrialFrom the Department of Plastic Surgery, Wythenshawe Hospital, Wythenshawe, Manchester, UK Correspondence: Ms V. C. Lees, Department of Plastic Surgery, Acute Block, Wythenshawe Hospital, Southmoor Road, Wythenshawe, Manchester M23 9LT, UK. Tel.: +44 161 291 6648; Fax: +44 161 291 6381; E-mail: v.lees{at}virgin.net. A prospective double-blind, randomized, controlled clinical trial was conducted to assess the use of ADCON-T/N after flexor tendon repair in Zone II. Forty-five patients with 82 flexor tendon repairs in 50 digits completed the study. ADCON-T/N was injected into the tendon sheath after tenorrhaphy in the experimental group while the control group was not treated with ADCON-T/N. ADCON-T/N had no statistically significant effect on total active motion at 3, 6 and 12 months but the time taken to achieve the final range of motion was significantly shorter in treated patients. ADCON-treated patients had a higher rupture rate but this was not significant.
Journal of Hand Surgery (British and European Volume), Vol. 28, No. 2,
113-115 (2003) This article has been cited by other articles:
|
||||||||||||||||
